Telis Bioscience is accelerating drug development by advancing rapid protein synthesis technology. Antibodies play a key role in many therapeutics, yet the design and manufacture of effective drugs can take months or years. Instead, Telis is using their antibody design engine to speed up this process to hours. Telis’ design engine uses three core platforms: [1] a rapid protein synthesis platform to purify hundreds of antibodies per day, [2] automated assays to screen antibody properties and [3] deep learning architectures to understand antibody fitness and generate optimized variants. Combined, Telis can use their approach to design lead antibodies optimized for safety, efficacy and manufacturability, all while by-passing the slow conventional development strategy.

<p>Telis Bioscience is accelerating drug development by advancing rapid protein synthesis technology. Antibodies play a key role in many therapeutics, yet the design and manufacture of effective drugs can take months or years. Instead, Telis is using their antibody design engine to speed up this process to hours. Telis’ design engine uses three core platforms: [1] a rapid protein synthesis platform to purify hundreds of antibodies per day, [2] automated assays to screen antibody properties and [3] deep learning architectures to understand antibody fitness and generate optimized variants. Combined, Telis can use their approach to design lead antibodies optimized for safety, efficacy and manufacturability, all while by-passing the slow conventional development strategy.</p>


Telis Bioscience

Founded: 2019
Location: Cambridge, MA
Employee range: 1-50
Funding: not disclosed

Short description:

Drug notes:

Long description:

Jobs: